chartexchange

AXSM
Axsome Therapeutics, Inc
stockNASDAQ

Market OpenNov 17, 2026 10:07:08 AM EST
137.00USD-0.007%(-0.01)66,013
Pre-marketNov 17, 2026 9:27:30 AM EST
139.01USD+1.462%(+2.00)
129.20Bid137.26Ask8.06Spread
Loading…
Loading…
Healthcare
Biotechnology
CEO
Herriot Tabuteau
HQ
New York, NY, USA
Previous Close
$136.88
Beta
0.70
52-Week High
$260.19 2026-06-18
52-Week Low
$123.00 2026-11-02
SMA 50
$170.05
SMA 200
$196.81
Avg. Vol 10D
1.10M
Avg. Vol 30D
1.09M
Avg. Vol 90D
822,742
Relative Vol
0.06
44.37M
0.2800%
649
AXSM Profile

axsome therapeutics is a biopharmaceutical company developing novel therapies for the treatment of cns disorders. axsome has a balanced portfolio of clinical development stage as well as research stage product candidates. the company is based in new york city.

AXSM Performance
PeriodPriceDateChangeBeta
1W140.972026-11-10-2.99%2.881
1M157.142026-10-16-12.97%1.012
3M216.272026-08-17-36.76%0.888
6M227.402026-05-18-39.86%0.628
1Y145.562025-11-17-6.05%0.705
2Y92.452024-11-18+47.93%—
5Y34.552021-11-17+295.83%0.868
AXSM Stock Summary

Axsome Therapeutics, Inc (NASDAQ:AXSM) stock price today is $136.76, and today's volume is 62,135. AXSM is down 0.182% today. The 30 day average volume is 1.09M. AXSM market cap is $7.19B with 52.60M shares outstanding.